Forty-four patients (48 wrists) with De Quervain's disease were randomized to receive an ultrasound-guided or blind corticosteroid injection (0.5 mL of 40mg/mL triamcinolone acetonide). Outcomes of interest included pain on a Visual Analog Scale (VAS), Patient-Rated Wrist Evaluation (PRWE) pain, functional, and total scores, the incidence of skin hypopigmentation/atrophy, hypopigmentation score on...